Nivolumab in Combination With GDP/ L-asparaginase in NK/ T-cell Lymphoma
- Status
- WITHDRAWN
- Phase
- PHASE1
Clinical Trials Related to Bristol-Myers Squibb
Related studies linked through entity extraction aliases.
Trial of Nivolumab and Cetuximab After Chemoradiation in Esophageal Squamous Cell Carcinoma Patients.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Deciphering Rheumatoid Arthritis-associated Interstitial Lung Disease Pathogenesis 2
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Prospective Epidemiological Study of Metastatic Non Small Cell Lung Cancer (NSCLC) in Latin America
- Status
- COMPLETED
- Phase
- N/A
A Single-dose Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of BMS-986263 in Participants With Varying Degrees of Liver Impairment
- Status
- COMPLETED
- Phase
- PHASE1
A Study Comparing the Effects of Famotidine Pretreatment and of Food on the Relative Bioavailability of BMS-986165 in Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Nivolumab Plus Bempegaldesleukin (Bempeg/NKTR-214) vs Nivolumab Alone vs Standard of Care in Participants With Bladder Cancer That May Have Invaded The Muscle Wall of the Bladder and Who Cannot Get Cisplatin, A Type of Medicine Given To Treat Bladder Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Study of VE800 and Nivolumab in Patients With Selected Types of Advanced or Metastatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of JNJ-70033093 and Digoxin in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
Nivolumab for Relapsed, Refractory, or Detectable Disease Post Chimeric Antigen Receptor T-cell Treatment in Patients With Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE2
Nivolumab for Treatment of Squamous Cell Carcinoma of the Skin
- Status
- RECRUITING
- Phase
- PHASE2
A Phase 1a/b Study of IK-175 as a Single Agent and in Combination With Nivolumab in Patients With Locally Advanced or Metastatic Solid Tumors and Urothelial Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1
Cabozantinib and Nivolumab for Carcinoid Tumors
- Status
- COMPLETED
- Phase
- PHASE2
A Retrospective Observational Study on the Long-term Effects of Ipilimumab-treated Pediatric Participants in the Dutch Melanoma Treatment Registry (DMTR)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Study to Assess Safety and Effectiveness of Branebrutinib Treatment in Participants With Active Systemic Lupus Erythematosus or Primary Sjögren's Syndrome, or Branebrutinib Treatment Followed by Open-label Abatacept Treatment in Study Participants With Active Rheumatoid Arthritis
- Status
- COMPLETED
- Phase
- PHASE2
Nivolumab With Chemotherapy in Pleural Mesothelioma After Surgery
- Status
- COMPLETED
- Phase
- PHASE2
A Study Assessing the Drug Levels, Drug Effects, and Safety of BMS-986322 in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
An Investigational Study to Evaluate Experimental Medication BMS-986165 Compared to Placebo in Participants With Plaque Psoriasis (POETYK-PSO-3) in Mainland China, Taiwan, and South Korea
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Nivolumab and Chemotherapy Followed by Surgery for Mesothelioma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study to Assess Overall Survival and Treatment Patterns for Advanced Liver Cancer Participants Who Received Nivolumab Therapy
- Status
- COMPLETED
- Phase
- N/A